Cao Yang 4
4 · Humacyte, Inc. · Filed Jan 23, 2025
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Cao Yang
Chief Regulatory Officer
Transactions
- Award
Stock Options (right to buy)
2025-01-21+283,101→ 283,101 totalExercise: $4.56Exp: 2035-01-21→ Common Stock (283,101 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on January 21, 2026, after which 1/48 of the option will become exercisable on the 21st of each month through January 21, 2029.